Eisai to Present Abstracts on Lenvatinib at 2022 ASCO Gastrointestinal Cancers Symposium Eisai Jan 17, 2022 10:44 HKT/SGT Read More
Eisai to Launch Digital Too "Cogmate" in Taiwan and Hong Kong for Self-Assessment of Brain Performance (Brain Health) Eisai Jan 13, 2022 12:26 HKT/SGT Read More
Greenheart CBD has Partnered with Paradigm Sports to Sponsor three MMA Fighters Greenheart CBD Jan 13, 2022 08:54 JST Read More
Eisai Enters Into Exclusive Licensing Agreement with Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator Eisai Jan 06, 2022 10:09 HKT/SGT Read More
B-cell lymphoma clinical trials now open on the TrialWire Platform TrialWire Jan 05, 2022 16:00 JST Read More
Investigational Alzheimer's Disease Therapy Lecanemab Granted FDA Fast Track Designation Eisai Dec 24, 2021 08:26 HKT/SGT Read More
Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer's Disease In The United States Eisai Dec 21, 2021 09:23 HKT/SGT Read More
Eisai Enters into Commercialization and Distribution Agreement with Gilead for JAK Inhibitor Filgotinib in Asia Eisai Dec 20, 2021 12:35 HKT/SGT Read More
Fujitsu and MIT's Center for Brains, Minds, and Machines Develop AI Technology Inspired by the Human Brain Able to Recognize Unseen Data with High Accuracy Fujitsu Ltd Dec 09, 2021 09:17 HKT/SGT Read More
